SAN ANTONIO George W. Sledge Jr., M.D., a nationally recognized pioneer in the development of novel therapies for breast cancer, will receive the 2010 William L. McGuire Memorial Lecture Award at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium.
Supported by GlaxoSmithKline Oncology (GSK) since its inception in 1992, this honor acknowledges distinguished internationally recognized researchers for their significant contributions to breast cancer research.
Sledge is the Ballve-Lantero Professor of Oncology and professor of medicine and pathology at the Indiana University School of Medicine, and a physician/ researcher at the Indiana University Melvin and Bren Simon Cancer Center. He is also co-director of the the IU Simon Cancer Center's breast program. Sledge specializes in the study and treatment of breast cancer, and his research specifically focuses on molecular and tumor biology, growth factors and anti-angiogenic therapy. He has chaired several nationwide clinical trials involving new therapies for breast cancer.
"Dr. Sledge's work developing novel therapies to treat women with breast cancer has improved the lives of countless cancer patients," said C. Kent Osborne, M.D., codirector of the San Antonio Breast Cancer Symposium and director of the Baylor College of Medicine Dan L. Duncan Cancer Center. "The selection of Dr. Sledge is even more appropriate since he was one of the first medical oncology fellows to graduate the new fellowship training program at the University of Texas Health Science Center Division of Medical Oncology, established by Dr. McGuire as division director in the late 1970s. We congratulate Dr. Sledge on this fitting honor."
Sledge will give a lecture entitled, "What Would Bill Do? Channeling Your Inner McGuire," on Saturday, Dec. 11, 2010, at 11:15 a.m. CT, during the 33rd Annual San Antonio Breast Cancer Symposium. This symposium, encompassing the full spectrum of breast cancer r
'/>"/>
| Contact: Michele Sharp michele.sharp@aacr.org 267-646-0622 American Association for Cancer Research Source:Eurekalert |